Italian luxury goods maker Prada is due on Friday to set the price range for its $2 billion initial public offering in Hong Kong.
Here are some facts about Prada's business history:
GLOBAL REACH
* Founded almost a century ago, Prada is run by designer Miuccia Prada and her chief executive husband Patrizio Bertelli.
Prada, which also owns Miu Miu, Church's and Car Shoe brands, plans to open about 80 stores annually over the next three years, 30 of them in Asia. It had 319 stores globally at Jan. 31, 2011.
Prada reported record sales of 2.1 billion euros ($3.02 billion) in 2010 and core earnings of 536 million euros.
Europe is its biggest market, accounting for 42 percent of sales, while Greater China and the rest of Asia-Pacific together account for 40 percent. Asia is its fastest-growing market.
FAMILY OWNERSHIP
* Miuccia Prada, her brother Alberto and sister Marina indirectly own 65 percent of Amsterdam-based Prada Holding BV. Bertelli's Luxembourg-based holding company Pa.Be owns the rest.
Prada Holding owns 94.887 percent of the fashion company Prada SpA. Six years ago Italian bank Intesa Sanpaolo bought the remaining 5.113 percent stake for 100 million euros.
Bertelli has transferred half his stake in Pa.Be. to three companies for succession purposes.
ASIA FACTOR
* Prada has debts of more than 1 billion euros -- partly due to a buying spree during the 1990s -- while its net profit more than doubled to 251 million euros in the 2010/11 year ended Jan. 31, helped by its retail network expansion and growth in Asia. Prada expects its Asian sales to overtake those in Europe over the next three years.
It plans to open design centres in Hong Kong and Paris this year.
HONG KONG IPO
* Prada has been considering an IPO for a decade. First planned for the Milan bourse, the offering is now to take place in Hong Kong, which accounted for about a fifth of global IPOs last year. The offering could value Prada at around 8 billion euros and allow it to draw Asian investors.
Hong Kong bourse guidelines would require management changes, including two executive administrators based in Hong Kong and three independent administrators.
Prada's IPO is slated to be priced on June 17, with listing on the Hong Kong stock exchange set for June 24. The roadshow starts on June 6.
Goldman Sachs, Credit Agricole's CLSA brokerage and Italian banks UniCredit SpA and Intesa Sanpaolo's Banca IMI unit, both on Prada's board, were picked as joint bookrunners and global coordinators of the IPO.
Prada has turned down approaches by private equity firms.
India's services sector expanded at its slowest pace in 20 months in May as soaring prices and interest rate hikes gnawed at new business growth and reduced the level of optimism, a survey showed on Friday.
The seasonally adjusted HSBC Markit Business Activity Index, based on a survey of over 400 firms, slipped to 55.0 in May from 59.2 in April, marking its twenty-fifth successive month above the 50 level that divides growth from contraction.
While the latest reading underlines a reasonably solid pace of growth in the services sector, its decline is an indication that continuous rate rises aimed at containing inflation are putting the brakes on India's rapid expansion.
The easing momentum for business activity and new business is evidence that policy tightening and high inflation is filtering through to growth, said Leif Eskesen, chief economist for India & ASEAN at HSBC.
All sub-indexes saw a fall when compared to April, with the exception of input costs and employment.
New business received by service companies remained strong but the pace of expansion slowed with the sub-index falling to its lowest level since October last year.
Among the sub-indexes, business expectations saw the steepest fall to 67.8 in May from 72.8 in April, as respondents, though confident of the sector's performance over the next 12 months, slightly tempered expectations as economic uncertainty loomed.
Data released earlier this week showed Asia's third-largest economy grew at its slowest annual pace in five quarters in January to March as consecutive interest rate hikes, aimed at reigning in soaring inflation, began to take effect.
Gross domestic product rose 7.8 percent from a year earlier, lower than 8.3 percent in the previous quarter and below the median 8.2 percent forecast in a poll.
While weaker-than-expected growth might cause the Reserve Bank of India (RBI) to raise rates in smaller increments, the survey showed price pressures will persist.
The RBI has no choice but to continue its tightening cycle to bring about a slowdown in domestic demand, which is sufficient to lessen capacity constraints and ease inflation pressures, Eskesen said.
Input costs increased markedly in May due to rising wage bills and raw material costs. Further inflation pressures are expected as the economy braces for an increase in government-controlled prices of diesel and cooking fuels.
Prices charged also rose in May as service providers transferred rising costs to consumers, but the slightly weaker pace suggested a slight reduction in margins.
Last month the RBI raised rates by half a percentage point, declaring some near-term growth would need to be sacrificed to tame inflation, which stood at 8.66 percent for April.
The service sector continued to add jobs with the index for employment signalling an increase in the pace of hiring.
Data released earlier in the week showed Indian manufacturing PMI dipped and factory growth eased globally, with the most pronounced slowdown seen in the United States.
Since corporate governance is on boil these days, I thought it would be interesting to have the fellow analyst/investors read a thorough investigative report on a chinese name listed in canada namely sino forest corp (mcap CAD 3.5 bn). The stock is down 20 percent since the report and the bonds are down 20 to 40 percent.
The analysis done in the report is real good and one could do such analysis for any small cap or mid cap in india also if someone really wanted to dig deep in one's holding or coverage.
Muddy waters report on initiating coverage on Sinoforest Corp(ticker TRE.TO)
Access the full report here:
Pharmaceutical Headlines for June 2, 2011 ( Thursday ).
• Silence Therapeutics plc to Close US Operations in Reorganization, Search on for New CEO More...
• AlphaRx International Holdings Limited Terminates Its Chief Scientist and Chief Medical Officer for Cause More...
• Marshall Edwards, Inc. (MSHL) Adds Former Genentech (RHHBY) Head of Medical Affairs Robert Mass as Chief Medical Officer More...
• Apricus Biosciences (APRI) Appoints Steve Martin as Senior Vice President and Chief Financial Officer More...
• Soligenix Appoints Joseph Warusz as Vice President of Administration and Controller More...
• British Firm Sagentia to Add Jobs in Massachusetts More...
• Novo Nordisk A/S (NVO) Will Boost China Investments to Fend Off Sanofi (France) (SASY.PA), COO Says More...
• Sequenom Inc. (SQNM) Enters Into New $30.0 Million Credit Facility More...
• Healthpoint Acquires Regranex® Gel More...
• Global Pharm Holdings Group Completes Acquisitions for Two City-Level Pharmaceutical Distribution Companies More...
• INC Research, Inc. Expands Reach in Australia, New Zealand and India WithTrident Clinical Research Acquisition More...
• Ortho-McNeil Pharmaceutical, Inc. Ditches $625 Million Diabetes Drug Pact with Diamyd Medical AB More...
• Bristol-Myers Squibb Canada (BMY) and Roche (RHHBY) Enter into a Clinical Collaboration Agreement to Conduct Combination Studies with YERVOY(TM) (ipilimumab) and Vemurafenib More...
• Teva Pharmaceutical Industries Limited (TEVA) Eyes Deals in India, Gets US OK for Generic Aricept More...
• Luminex Corporation (LMNX) and Life Technologies (LIFE) Sign Agreement for Global Distribution of the Award-Winning MAGPIXĂ‚® Multiplexing Instrument More...
• Goodwin Biotechnology, Inc. Announces a Collaboration With Alethia BioTherapeutics, Inc. More...
• PAREXEL International (PRXL) Issues Earnings Guidance in Conjunction with Investor Day More...
• South Carolina Prosecutor Suing GlaxoSmithKline (GSK) Over Avandia More...
• GlaxoSmithKline (GSK) and Theravance, Inc. (THRX) Announce Results of Two Pivotal Phase III Studies for Relovair(TM) in COPD; Results Support Continuation of Development Program More...
• Adeona Pharmaceuticals (AEN) Announces Positive Alzheimer's Subgroup Analysis that Supports Additional Clinical Study of Proprietary Zinc-Based Therapy More...
• Lpath, Inc.'s Anti-LPA Antibody, Lpathomab, Demonstrates Promising Data in Several Animal Models of Disease More...
• Seaside Therapeutics Initiates Pivotal Phase 3 Study of STX209 in Fragile X Syndrome More...
• Mylan Laboratories Inc. (MYL) Receives Approval for Generic Version of Effexor XR(R) Capsules More...
• NovaDel Pharma (NVD) Reports Opening of Duromist(TM) Original IND with FDA More...
• Vaccine May Help Treat Advanced Melanoma: M. D. Anderson Cancer Center More...
• Cholesterol Drugs Tied to Lower Prostate Cancer Risk, Duke University School of Medicine Study More...
• FDA: Treatment With Angiotensin Receptor Blockers for High Blood Pressure Does Not Increase Risk of Cancer More...
• Childhood ADHD Linked to Later Risk of Drug Abuse: Journal of the American Academy of Child & Adolescent Psychiatry More...
• Silence Therapeutics plc to Close US Operations in Reorganization, Search on for New CEO More...
• AlphaRx International Holdings Limited Terminates Its Chief Scientist and Chief Medical Officer for Cause More...
• Marshall Edwards, Inc. (MSHL) Adds Former Genentech (RHHBY) Head of Medical Affairs Robert Mass as Chief Medical Officer More...
• Apricus Biosciences (APRI) Appoints Steve Martin as Senior Vice President and Chief Financial Officer More...
• Soligenix Appoints Joseph Warusz as Vice President of Administration and Controller More...
• British Firm Sagentia to Add Jobs in Massachusetts More...
• Novo Nordisk A/S (NVO) Will Boost China Investments to Fend Off Sanofi (France) (SASY.PA), COO Says More...
• Sequenom Inc. (SQNM) Enters Into New $30.0 Million Credit Facility More...
• Healthpoint Acquires Regranex® Gel More...
• Global Pharm Holdings Group Completes Acquisitions for Two City-Level Pharmaceutical Distribution Companies More...
• INC Research, Inc. Expands Reach in Australia, New Zealand and India WithTrident Clinical Research Acquisition More...
• Ortho-McNeil Pharmaceutical, Inc. Ditches $625 Million Diabetes Drug Pact with Diamyd Medical AB More...
• Bristol-Myers Squibb Canada (BMY) and Roche (RHHBY) Enter into a Clinical Collaboration Agreement to Conduct Combination Studies with YERVOY(TM) (ipilimumab) and Vemurafenib More...
• Teva Pharmaceutical Industries Limited (TEVA) Eyes Deals in India, Gets US OK for Generic Aricept More...
• Luminex Corporation (LMNX) and Life Technologies (LIFE) Sign Agreement for Global Distribution of the Award-Winning MAGPIXĂ‚® Multiplexing Instrument More...
• Goodwin Biotechnology, Inc. Announces a Collaboration With Alethia BioTherapeutics, Inc. More...
• PAREXEL International (PRXL) Issues Earnings Guidance in Conjunction with Investor Day More...
• South Carolina Prosecutor Suing GlaxoSmithKline (GSK) Over Avandia More...
• GlaxoSmithKline (GSK) and Theravance, Inc. (THRX) Announce Results of Two Pivotal Phase III Studies for Relovair(TM) in COPD; Results Support Continuation of Development Program More...
• Adeona Pharmaceuticals (AEN) Announces Positive Alzheimer's Subgroup Analysis that Supports Additional Clinical Study of Proprietary Zinc-Based Therapy More...
• Lpath, Inc.'s Anti-LPA Antibody, Lpathomab, Demonstrates Promising Data in Several Animal Models of Disease More...
• Seaside Therapeutics Initiates Pivotal Phase 3 Study of STX209 in Fragile X Syndrome More...
• Mylan Laboratories Inc. (MYL) Receives Approval for Generic Version of Effexor XR(R) Capsules More...
• NovaDel Pharma (NVD) Reports Opening of Duromist(TM) Original IND with FDA More...
• Vaccine May Help Treat Advanced Melanoma: M. D. Anderson Cancer Center More...
• Cholesterol Drugs Tied to Lower Prostate Cancer Risk, Duke University School of Medicine Study More...
• FDA: Treatment With Angiotensin Receptor Blockers for High Blood Pressure Does Not Increase Risk of Cancer More...
• Childhood ADHD Linked to Later Risk of Drug Abuse: Journal of the American Academy of Child & Adolescent Psychiatry More...
Tech Five: Technology Headlines for June, 2 2011 ( Thursday ) !!
1. Ending weeks of offline misery after high-profile hack attacks, Sony's PlayStation Store is back online. Sony's thanking everyone for "patience" and notes the Store has been topped up with a lot of content (there's even a handy list of the new gaming goodness). But the "welcome back" free offers, given to PSN users as an apology for the extended outage, isn't yet live--it's in final testing. Presumably so Sony doesn't expose itself with yet another security hole.
2. YouTube now lets you license your uploaded video under Creative Commons. Essentially this means you can choose to give permission for other folk to reuse, rework, adapt and republish your efforts--with attribution to you as an original source. It's important because it lets YouTube become a bigger channel for newly produced content, which helps keep it relevant and growing. YouTube's even pre-arranged some 10,000 clips from C-SPAN, Al-Jazeera, and more.
3. In a bill which music industry patrons hope will set a trend, Tennessee has a new law that makes it illegal to use someone else's login credentials to listen to music or watch streaming TV content from systems like Netflix or Rhapsody. The Web Entertainment Theft legislation, which seems draconian because it's valid even if you have permission, is directed at hackers who resell passwords in bulk, but sponsors acknowledge it applies to everyone--particularly college-goers.
4. Apple just updated its OS X to defeat a persistent and tricky malware attack called Mac Defender that may be the highest profile "hack" of Apple's OS yet--although strictly it needs user interaction to "infect" a machine. But within hours the illegal coders behind the attack adjusted their system to circumvent Apple's new security. Apple's now got a system for daily security updates, but it's a sign malware attackers are targeting the oft-overlooked Mac.
5. Shaq--yup, that Shaq--just announced his retirement from the NBA via Twitter. Specifically O'Neal used Tout, a social video sharing system to make it a truly 21st century retirement posting. No letter, no newspaper leak, no press conference, just a simple, honest self-published social networking status update.
( Source: Fast Company )
Daily Digest Stockinvestips |
Upgrades for June 2, 2011 Thursday:
1) Affymetrix ( NASDAQ: AFFX) upgraded from neutral to Outperform by Robert W. Baird.
2) Apollo Investment ( NASDAQ :AINV ) upgraded from neutral to buy by Ladenburg Thalmann.
3) FSI Intl ( NASDAQ: FSII) upgraded from hold to buy by Needham.
4) HHGregg ( NYSE: HGG) upgraded from Above Average to buy by Caris & Company.
5) Hill International ( NYSE: HIL) upgraded from neutral to outperform by Boenning & Scattergood.
6) Inergy ( NYSE: NRGY ) upgraded from neutral to outperform by Robert W. Baird.
7) Microsoft ( NASDAQ : MSFT ) upgraded from hold to buy by Standpoint Research.
See More
Downgrades for June 2, 2011 Thursday:
1) Check Point Software (NASDAQ : CHKP) downgraded from buy to neutral by Davenport.
2) Cracker Barrel ( NASDAQ : CBRL ) downgraded from buy to hold by Argus.
3) Energy Solutions ( NYSE : ES ) downgraded from outperform to neutral by Wedbush.
4) Sabesp ( NYSE : SBS ) downgraded from buy to hold by Standpoint Research.
5) Telvent ( NASDAQ : TLVT) downgraded from outperform to neutral by Wedbush.
6) Zumiez ( NASDAQ : ZUMZ) downgraded from buy to neutral by Janney Mntgmy Scott.
See More
Coverage Initiated for June 2, 2011 Thursday:
1) Achillion Pharma ( NASDAQ : ACHN ) coverage initiated with buy by Brean Murray.
2) Anadys Pharma ( NASDAQ: ANDS ) coverage initiated with hold by Brean Murray.
3) Express ( NYSE : EXPR ) coverage initiated with strong buy by Brean Murray.
4) Idenix Pharma ( NASDAQ: IDIX ) coverage initiated with sell by Brean Murray.
5) Inhibitex ( NASDAQ: INHX ) coverage initiated with buy by Brean Murray.
6) Pharmasset ( NASDAQ: VRUS ) coverage initiated with buy by Brean Murray.
7) Roadrunner Transportation ( NASDAQ: RRTS ) coverage initiated with outperform by Morgan Keegan.
8) TranSwitch ( NASDAQ: TXCC ) coverage initiated with buy by Needham.
See More here at stockinvestips
Hill International Inc ( NYSE: HIL ) announced winning of contract of $3 million. Stock jumped more than 50% based on news. It has touched a new 52 week high of $ 7.38, it might be considered a breakout.
Hill International, the U.S. construction consulting firm, received a 4.7 million-real ($3 million) contract to expand a wind farm in Brazil.
Hill’s recently acquired Brazil unit Engineering SA will oversee the installation of 61 additional turbines at a New Energy Options Geracao de Energia project in the northern state of Rio Grande do Norte, Marlton, New Jersey-based Hill said in a statement yesterday. The expansion will cost a total of 592 million reais.
Our Call: Small buy positions for trading purpose.
Below is the detailed news:
Hill International Inc |
Hill International, the U.S. construction consulting firm, received a 4.7 million-real ($3 million) contract to expand a wind farm in Brazil.
Hill’s recently acquired Brazil unit Engineering SA will oversee the installation of 61 additional turbines at a New Energy Options Geracao de Energia project in the northern state of Rio Grande do Norte, Marlton, New Jersey-based Hill said in a statement yesterday. The expansion will cost a total of 592 million reais.